Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD

EMBO Journal

Volumn 22, Issue 12, 2003, Pages 3062-3072

  Baas, A F ^a   Boudeau, J ^c   Sapkota, G P ^c   Smit, L ^a   Medema, R ^b   Morrice, N A ^c   Alessi, D R ^c   Clevers, H C ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adaptor; LKB1; Pseudokinase; STE20 like kinase; STRAD

Indexed keywords

ADAPTOR PROTEIN; PROTEIN KINASE LKB1; PROTEIN SERINE THREONINE KINASE; PROTEIN STRAD; RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CATALYSIS; CELL CYCLE G1 PHASE; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE; CELL LINE; COS CELLS; ENZYME ACTIVATION; HUMANS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; PEUTZ-JEGHERS SYNDROME; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RATS; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY;

ANIMALIA;

EID: 0038614742     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg292     Document Type: Article

References (41)

1. Bardeesy, N., Sinha, M., Hezel, A.F., Signoretti, S., Hathaway, N.A., Sharpless, N.E., Loda, M., Carrasco, D.R. and DePinho, R.A. (2002) Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature, 419, 162-167.
2. Brummelkamp, T.R., Bernards, R. and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-552.
3. Campbell, D.G. and Morrice, N.A. (2002) Identification of protein phosphorylation sites by a combination of mass spectrometry and solid phase Edman sequencing. J. Biomol. Tech., 13, 121-132.
4. Candotti, F. et al. (1997) Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood, 90, 3996-4003.
5. Castrop, J., van Wichen, D., Koomans-Bitter, M., Van de, W.M., de Weger, R., van Dongen, J. and Clevers, H. (1995) The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed'in normal and neoplastic T-lineage lymphocytes. Blood, 86, 3050-3059.
6. Chen, M., Cheng, A., Candotti, F., Zhou, Y.J., Hymel, A., Fasth, A., Notarangelo, L.D. and O'Shea, J.J. (2000) Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol., 20, 947-956.
7. Collins, S.P., Reoma, J.L., Gamm, D.M. and Uhler, M.D. (2000) LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem. J., 345, 673-680.
8. Dan, I. et al. (2000) Molecular cloning of MINK, a novel member of mammalian GCK family kinases, which is up-regulated during postnatal mouse cerebral development. FEBS Lett., 469, 19-23.
9. Dan, I., Watanabe, N.M. and Kusumi, A. (2001) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol., 11, 220-230.
10. Fu, C.A., Shen, M., Huang, B.C., Lasaga, J., Payan, D.G. and Luo, Y. (1999) TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J. Biol. Chem., 274, 30729-30737.
11. Giardiello, F.M., Brensinger, J.D., Tersmette, A.C., Goodman, S.N., Petersen, G.M., Booker, S.V., Cruz-Correa, M. and Offerhaus, J.A. (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119, 1447-1453.
12. Hemminki, A. et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature, 391, 184-187.
13. Huse, M. and Kuriyan, J. (2002) The conformational plasticity of protein kinases. Cell, 109, 275-282.
14. Jeghers, H., McKusick, V.A. and Karz, K.H. (1949) Generalised intestinal polyposis and melanin spots of oral mucosa, lips and digits: a syndrome of diagnostic significance. N. Engl. J. Med., 241, 992-1005.
15. Jenne, D.E., Reimann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., Muller, O., Back, W. and Zimmer, M. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet., 18, 38-43.
16. Jishage, K. et al. (2002) Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc. Natl Acad. Sci. USA, 99, 8903-8908.
17. Johnston, A.M., Naselli, G., Gonez, L.J., Martin, R.M., Harrison, L.C., and DeAizpurua, H.J. (2000) SPAK, a STE20/SPS1-related kinase 'that activates the p38 pathway. Oncogene, 19, 4290-4297.
18. Karuman, P. et al. (2001) The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol. Cell, 7, 1307-1319.
19. Luo, H., Rose, P., Barber, D., Hanratty, W.P., Lee, S., Roberts, T.M., D'Andrea, A.D. and Dearolf, C.R. (1997) Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol., 17, 1562-1571.
20. Macchi, P. et al. (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature, 377, 65-68.
21. Marignani, P.A., Kanai, F. and Carpenter, C.L. (2001) LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J. Biol. Chem., 276, 32415-32418.
22. Martin, S.G. and St Johnston, D. (2003) A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature, 421, 379-384.
23. Miyoshi, H., Nakau, M., Ishikawa, T.O., Seldin, M.F., Oshima, M. and Taketo, M.M. (2002) Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res., 62, 2261-2266.
24. Nakau, M., Miyoshi, H., Seldin, M.E., Imamura, M., Oshima, M., and Taketo,M.M. (2002) Hepatocellular carcinoma caused by loss of heterozygosity in lkb1 gene knockout mice. Cancer Res., 62, 4549-4553.
25. Nezu, J., Oku, A. and Shimane, M. (1999) Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem. Biophys. Res. Commun., 261, 750-755.
26. Nishigaki, K., Thompson D., Yugawa, T., Rulli K., Hanson C., Cmarik J., Gutkind J.S., Teramoto H. and Ruscetti S. (2003) Identification and characterization of a novel Ste-20/GCK-related kinase, PAP kinase (PAPK). J. Biol. Chem., 278, 13520-13530.
27. Peutz, J.L. (1921) On a very remarkable case of familial polyposis of the mucous membrane of the intestinal tract and nasopharynx accompanied by peculiar pigmentation of the skin and mucous membranes. Ned. Tijdschr. Geneeskd., 10, 134-146.
28. Rossi, D.J. et al. (2002) Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc. Natl Acad. Sci. USA, 99, 12327-12332.
29. Saharinen, P. and Silvennoinen, O. (2002) The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J. Biol. Chem., 277, 47954-47963.
30. Saharinen, P., Takaluoma, K. and Silvennoinen, O. (2000) Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Cell. Biol., 20, 3387-3395.
31. Sanna, M.G., Da Silva, C.J., Luo, Y., Chuang, B., Paulson, L.M., Nguyen, B., Deveraux, Q.L. and Ulevitch, R.J. (2002) ILPIP, a novel anti-apoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis. J. Biol. Chem., 277, 30454-30462.
32. 433, is essential for LKB1 to suppress, cell growth. J. Biol. Chem., 276, 19469-19482.
33. Sapkota, G.P., Boudeau, J., Deak, M., Kieloch, A., Morrice, N. and Alessi, D.R. (2002) Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem. J., 362, 481-490.
34. Smith, D.P., Rayter, S.I., Niederlander, C., Spicer, J., Jones C.M. and Ashworth, A. (2001) LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB 1. Hum. Mol. Genet., 10, 2869-2877.
35. Su, Y.C., Han, J., Xu, S., Cobb, M. and Skolnik, E.Y. (1997) NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain. EMBO J., 16, 1279-1290.
36. 1 cell cycle arrest. Proc. Natl Acad. Sci. USA, 96, 9248-9251.
37. CIPI. Hum. Mol. Genet., 11, 1497-1504.
38. Watts, J.L., Morotn, D.G., Bestman, J. and Kemphues, J. (2000) The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development, 127, 1467-1475.
39. Wilks, A.F., Harpur, A.G., Kurban, R.R., Ralph, S.J., Zurcher, G. and Ziemiecki, A. (1991) Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol. Cell. Biol., 11, 2057-2065.
40. Yeh, T.C., Dondi, E., Uze, G. and Pellegrini, S. (2000) A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling. Proc. Natl Acad. Sci. USA, 97, 8991-8996.
41. Ylikorkala, A., Rossi, D.J., Korsisaari, N. Luukko, K., Alitalo, K., Henkemeyer, M. and Makela, T.P. (2001) Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science, 293, 1323-1326.